Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Post

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Molecular Cancer Therapeutics|October 10, 2023
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in LymphomaMason McCrury, Kennith Swafford, Sydnye L Shuttleworth, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer ModelsAlicja Urbaniak, Billie Heflin, Eric R Siegel, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2017
A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and DiseaseMercy R PrabhuDas, Cynthia L Baldwin, Paul L Bollyky, et al.
Frontiers in Oncology|December 2, 2022
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapyYuguo Zhang, Musa Gabere, Mika A Taylor, et al.
Nature|July 26, 2019
Flower isoforms promote competitive growth in cancerEsha Madan, Christopher J Pelham, Masaki Nagane, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Pancreatic tumor microenvironment reprogramming via alloantigenexpressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Journal for Immunotherapy of Cancer|May 12, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Frontiers in Immunology|October 27, 2025
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma modelsMulu Z Tesfay, Aleksandra Cios, Khandoker Usran Ferdous, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Molecular Cancer Therapeutics|October 10, 2023
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in LymphomaMason McCrury, Kennith Swafford, Sydnye L Shuttleworth, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Evaluation of the Activity of Monensin and Its Analogs for Modulation of Stem-like Cell Functionality in 2D and 3D Breast Cancer ModelsAlicja Urbaniak, Billie Heflin, Eric R Siegel, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2017
A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and DiseaseMercy R PrabhuDas, Cynthia L Baldwin, Paul L Bollyky, et al.
Frontiers in Oncology|December 2, 2022
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapyYuguo Zhang, Musa Gabere, Mika A Taylor, et al.
Nature|July 26, 2019
Flower isoforms promote competitive growth in cancerEsha Madan, Christopher J Pelham, Masaki Nagane, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Pancreatic tumor microenvironment reprogramming via alloantigenexpressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Journal for Immunotherapy of Cancer|May 12, 2026
Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy responseMulu Z Tesfay, Aleksandra Cios, Zetao Cheng, et al.
Frontiers in Immunology|October 27, 2025
Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma modelsMulu Z Tesfay, Aleksandra Cios, Khandoker Usran Ferdous, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Pageof 28